negative regulation of glomerular mesangial cell proliferation

Definition

Target type: biologicalprocess

Any process that decreases the frequency, rate or extent of glomerular mesangial cell proliferation. [GOC:mtg_kidney_jan10]

Negative regulation of glomerular mesangial cell proliferation is a critical process in maintaining the normal structure and function of the kidney. Mesangial cells, located in the space between glomerular capillaries, play a vital role in regulating glomerular filtration. Dysregulation of their proliferation can contribute to the development of various kidney diseases, including glomerulonephritis.

The process of negative regulation of glomerular mesangial cell proliferation involves a complex interplay of various signaling pathways and regulatory factors.

**Key Players:**

* **Transforming Growth Factor-beta (TGF-beta):** TGF-beta is a potent growth factor that can both promote and inhibit cell proliferation, depending on the context. In the context of glomerular mesangial cells, TGF-beta primarily acts as an inhibitor of proliferation. It does this by inducing the expression of cell cycle inhibitors like p21 and p27, which arrest cell cycle progression.

* **Platelet-Derived Growth Factor (PDGF):** PDGF is a potent mitogen for mesangial cells, stimulating their proliferation and contributing to the development of glomerular sclerosis. Factors that negatively regulate PDGF signaling or its downstream pathways play a role in inhibiting mesangial cell proliferation.

* **Angiotensin II (Ang II):** Ang II, a potent vasoconstrictor, can stimulate mesangial cell proliferation in certain conditions. However, in other contexts, Ang II can also act as an inhibitor of mesangial cell growth by inducing the production of TGF-beta.

* **Cytokines:** Various cytokines, including interferon-gamma (IFN-gamma) and interleukin-10 (IL-10), have been shown to influence mesangial cell proliferation. IFN-gamma can inhibit proliferation, while IL-10 can have both stimulatory and inhibitory effects.

**Mechanisms of Regulation:**

* **Cell Cycle Arrest:** Negative regulators of mesangial cell proliferation often act by arresting cell cycle progression. This can involve upregulating cell cycle inhibitors (like p21 and p27) or downregulating cell cycle promoting proteins (like cyclin D1).

* **Apoptosis Induction:** Some factors, like TGF-beta, can induce apoptosis in mesangial cells, effectively eliminating proliferating cells.

* **Extracellular Matrix Modulation:** Mesangial cells are involved in the production of the extracellular matrix (ECM) in the glomerulus. Factors that influence ECM deposition can indirectly impact mesangial cell proliferation. For example, TGF-beta promotes ECM production, which can contribute to a negative feedback loop by limiting mesangial cell growth.

**Clinical Implications:**

Understanding the mechanisms of negative regulation of mesangial cell proliferation is crucial for developing novel therapeutic strategies for kidney diseases. Targeting key players in these pathways, like TGF-beta or PDGF, could potentially prevent or reverse mesangial cell hyperproliferation and its associated pathologies.

**Further Research:**

Continued research is needed to further elucidate the complex signaling pathways and regulatory mechanisms involved in negative regulation of mesangial cell proliferation. Identifying novel targets and developing specific therapeutic interventions could significantly improve the treatment of kidney diseases.'
"

Proteins (1)

Compounds (3)